WATERTOWN, Mass., March 17, 2011 /PRNewswire/ -- A recently issued patent extends protection of the technology incorporated in Exergen's award winning and best selling medical thermometer brand, the TemporalScanner™ Temporal Artery Thermometers. Exergen Corporation has recently been granted U.S. Patent No. 7,787,938, entitled, "Temporal Artery Temperature Detector" by the US Patent and Trademark Office, adding to the already extensive Exergen portfolio of valuable intellectual property rights that it has developed for its non-invasive thermometry products.
With 15 US Patents protecting the TemporalScanner professional versions, and 10 US Patents protecting the home model, Exergen continues to vigorously defend its intellectual property rights. It has brought a number of lawsuits over the years to successfully stop companies from infringing upon Exergen's rights with regard to infrared temperature measuring products. Currently Exergen has brought suit against Kidz-Med, Inc., American Scientific Resources, Inc. and Tecnimed S.R.L for patent infringement in the United States District Court for the District of Massachusetts.
"This new patent confirms and protects important innovations in non-invasive thermometry contained in our Temporal Artery Thermometers," said Dr. Francesco Pompei, Exergen CEO and inventor of the patented technology. "These innovations are central to the overwhelming success of the temporal artery method, which many competitors would like to use. As a U.S. manufacturer we rely on strong patent protection to protect our rights, and do our part to help protect the spirit of innovation in a highly competitive world."
Exergen Corporation is recognized worldwide as an innovator and leading manufacturer of patented infrared thermometers, scanners, sensors and controls. Its products are used in a wide variety of industrial and medical applications for both professionals and consumers. Its T